Procter & Gamble Health Limited (NSE:PGHL)

Market Cap	90.63B -14.0%
Revenue (ttm)	14.33B +12.6%
Net Income	3.57B +18.7%
EPS	189.94 +5.0%
Shares Out	n/a
PE Ratio	25.39
Forward PE	24.29
Dividend	205.00 (3.76%)
Ex-Dividend Date	Aug 27, 2026

Volume	6,063
Open	5,425.00
Previous Close	5,460.00
Day's Range	5,414.00 - 5,527.00
52-Week Range	4,707.00 - 6,975.00
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. The company operates as a subsidiary o...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 1,276
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PGHL

Financial Performance

In fiscal year 2026, Procter & Gamble Health's revenue was 14.08 billion, an increase of 15.59% compared to the previous year's 12.18 billion. Earnings were 3.27 billion, an increase of 30.14%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 17, 2026

Data Sources Report a data error